HIV-1 subtype C LTR Sp1IIIT5A mutant enhances transcription activity and Sp1 binding affinity
Preprint
Abstract
Background: Genetic variation within HIV-1 subtype C (HIV-1C) long terminal repeat (LTR) transmitted/founder viruses influences transcription activation and clinical disease outcomes. The role of specific mutations such as thymine-to-adenine (T5A) mutation at position five of the Specificity protein 1 (Sp1) III motif (Sp1IIIT5A) remains underexplored. This study investigates the impact of Sp1IIIT5A on HIV-1C LTR transcription activity and Sp1 binding affinity. Methods: The Sp1IIIT5A mutant and consensus HIV-1C LTR sequences were cloned into the pGL3 Luciferase Basic reporter vector, sequenced, and transfected into SVG and Jurkat cell lines, independently. Transcription activity and Sp1 expression were assessed via luciferase assays and Western blot. Structural models of Sp1IIIT5A, consensus LTRs and Sp1 were generated, and docking scores calculated using HDOCK, HADDOCK, and pyDockDNA. Molecular dynamics simulations analyzed stability and interactions of Sp1IIIT5A LTR-Sp1 complexes. Results and Discussion: The Sp1III5A mutant significantly increased basal (SVG: p<0.0001; Jurkat: p=0.0052) and Tat-mediated (SVG and Jurkat: p<0.0001) HIV-1C LTR transcription activity in both cell lines, with stronger effects in SVG cells. Sp1 expression levels remained similar across cell lines (p=0.0814). Sp1III5A exhibited higher binding affinity (-332.7, -174.6, and -279.2 kcal/mol) than the canonical sequence (-311.4, -157.0, and -247.3 kcal/mol). Conclusion: The Sp1IIIT5A mutation significantly enhances HIV-1C LTR transcription activity and Sp1 binding affinity, indicating its potential tole in modulating HIV-1C transcription and pathogenesis. Further investigation is needed to elucidate its impact on HIV-1C latency. Importance: In this study we show that the thymine-to-adenine (T5A) mutation at position five of the Sp1 III motif (Sp1IIIT5A) within the HIV-1 subtype C (HIV-1C) long terminal repeat (LTR) increases viral transcription. This mutation enhances the interaction between HIV-1C and the cellular transcription factor Sp1, promoting the viral strain’s ability to replicate. Our findings provide insight into why certain HIV-1C strains behave differently, potentially leading to heterogenous rates of disease progression. Understanding the Sp1IIIT5A mutation could lead to improved strategies for controlling HIV-1C and developing cure strategies to clear the infection or result in virus remission.Keywords
This publication has 40 references indexed in Scilit:
- Integrating Molecular Docking and Molecular Dynamics Simulations2019
- IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency ReactivationCell Host & Microbe, 2019
- What method to use for protein–protein docking?Current Opinion in Structural Biology, 2019
- Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysisThe Lancet Infectious Diseases, 2019
- Clustal Omega for making accurate alignments of many protein sequencesProtein Science, 2017
- Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene ExpressionBiophysical Journal, 2010
- Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progressionJournal of Neuroimmunology, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Activity of Human Immunodeficiency Virus Type 1 Promoter/TAR Regions andtat1 Genes Derived from Individuals with Different Rates of Disease ProgressionVirology, 1997
- Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivatorsCell, 1993